As scientific output grows, the risk of a promising drug getting lost increases, but advances in artificial intelligence and machine learning may prevent that.
A new technique boosts the sensitivity of mass cytometry to allow detection and characterization of low-abundance markers, yielding new disease insights.
Researchers discovered an immunological connection between the eye and the brain that could lead to new therapeutics for central nervous system diseases.